Dr. Dayan Goodenowe draws renewed attention for brain health research

By AI, Created 12:41 PM UTC, May 27, 2026, /AGP/ – Scientist and Prodrome Sciences founder Dr. Dayan Goodenowe is getting new attention after an MSN feature highlighted his work on brain health, cognitive performance and longevity medicine. His research centers on plasmalogens, a class of lipids he says may help explain aging-related decline in the brain and body.

Why it matters: - Dr. Dayan Goodenowe is pushing a preventive model for brain health at a time when interest in cognitive decline, dementia and longevity medicine is rising. - His work may influence how people think about measuring biological decline before symptoms become severe. - The attention adds visibility to plasmalogen science, a niche field tied to neurological function and aging.

What happened: - Dr. Dayan Goodenowe, founder of Prodrome Sciences, received renewed national attention after being featured in an MSN article about brain health, cognitive performance and longevity. - The feature highlighted his long-running work on plasmalogen science and its possible role in neurological restoration. - Goodenowe has spent more than 30 years researching the biochemistry of neurological function, aging and cellular resilience.

The details: - Goodenowe’s research focuses on how declining plasmalogen levels may relate to brain shrinkage, cognitive decline, neurodegeneration, inflammation and metabolic dysfunction. - His work centers on advanced tools including ion cyclotron mass spectrometry and magnetic resonance imaging. - Plasmalogens are essential lipids involved in cellular membranes and neurological function, and levels naturally decline with age and disease. - Goodenowe said brain health should be addressed earlier in life, not after decline becomes obvious. - Goodenowe wrote that his approach aims to measure deviations from health, called prodromes, before catastrophic decline occurs and to restore those deviations using advanced nutrition and biochemistry. - Goodenowe has also argued for a model that emphasizes prevention, optimization and individual biological awareness. - His work attracts interest from physicians, researchers, biohackers, entrepreneurs, athletes and families looking for options beyond conventional treatment pathways. - Goodenowe says his approach remains rooted in measurable biology, data-driven analysis and scientific investigation. - His health initiatives include advanced testing, education and community-based outreach. - In an op-ed on personal health autonomy, Goodenowe wrote: “We do not diagnose disease. We measure health. We do not treat disease. We restore health through education and access.” - Goodenowe also wrote that his team provides education and access to information and technologies that help people better understand their biology and take part more actively in their health journey. - The release says Goodenowe is not a medical doctor. - The release identifies him as a scientist, inventor and expert in plasmalogen biology and brain health. - The release says he invented plasmalogen precursors for restoration and augmentation of plasmalogens in the brain and body.

Between the lines: - The MSN feature appears to be part of a broader mainstreaming of longevity and brain-optimization coverage. - Goodenowe’s message fits a larger shift toward proactive health management, but the claims around restoration and prevention remain part of his scientific and public positioning rather than established clinical consensus. - The release positions Prodrome Sciences as part research platform, part education effort, and part consumer-facing health movement.

What’s next: - Goodenowe says the next phase of healthcare will focus on preserving function before it disappears. - The release suggests he will continue expanding research, educational outreach and a global community centered on proactive brain and body health. - Public interest in brain optimization and longevity medicine is expected to keep growing as more people look for ways to maintain cognition, energy and independence later in life.

The bottom line: - Dr. Dayan Goodenowe is using growing media attention to advance a prevention-first message: measure biological decline earlier, then try to restore health before disease takes hold.